| Date | Time | Source | Headline | Symbol | Company |
| 27/03/2015 | 01:12 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 18/02/2015 | 04:10 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 21/02/2014 | 09:00 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 05/11/2013 | 06:23 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 30/10/2013 | 21:00 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 29/10/2013 | 10:51 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 29/10/2013 | 10:39 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 29/10/2013 | 09:09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 29/10/2013 | 08:58 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 29/10/2013 | 08:42 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 29/10/2013 | 08:11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 29/10/2013 | 07:51 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 29/10/2013 | 06:53 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 29/10/2013 | 06:24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 29/10/2013 | 06:08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 29/10/2013 | 05:21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 26/10/2013 | 08:25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 25/10/2013 | 05:32 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 25/10/2013 | 05:32 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 25/10/2013 | 05:32 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 25/10/2013 | 05:31 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 25/10/2013 | 05:31 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 25/10/2013 | 05:31 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 25/10/2013 | 05:31 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 25/10/2013 | 05:30 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 25/10/2013 | 05:29 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 25/10/2013 | 03:55 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 25/10/2013 | 00:47 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 07:32 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 16/10/2013 | 00:23 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |